In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 71 for your search:
Drug:  incomplete Freund's adjuvant
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10464, UVACC-MEL-41, UVACC-28502, UVACC-HIC-10464, NCT00089219

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000430929, UVACC-HIC-11491, UVACC-34104, UVACC-MEL-44, UVACC-GCRC-CLS013, UVACC-HITC-02620, MDA-2005-0070, Mel 44, NCT00118274

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LUD2003-007, NCT00145158

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12095B, NCT00203892

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 to 80
Sponsor: Other
Protocol IDs: FPCR1R2-2, NCT00655785

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 85
Sponsor: Other
Protocol IDs: IMU-H21-40-P?/?, NCT01225471

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 29810, NCT01312389

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 030162, 03-C-0162, NCI-5855, CDR0000304438, NCT00062036

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 030172, 03-C-0172, NCI-03-C-0172, NCI-6211, 6211, NCT00062218, NCT00059475

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000335055, U10CA021115, E1602, ECOG-E1602, NCT00071981

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000335441, NCI-03-C-0299, NCI-6210, 6210, NCT00072085

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-04-C-0083, MDX-010-19, NCI-6532, 6532, NCT00077532

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000354491, NCI-04-C-0104, NCI-6233, 6233, NCT00079144

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000365467, P30CA076292, P30CA014089, MCC-15241, MDX010-16, NCI-6446, CA184-016, 6446, LAC-USC-10M036, NCT00084656

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 10M-03-3, NCI-2012-02593, CDR0000367485, LAC-USC-10M033, LAC-USC-IRB-942010, NCI-6451, 6451, NCT00085189

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02618, LAC-USC-042011, NCI-6618, LAC-USC-0A1033, CDR0000378033, 10M-03-8, 6618, LAC-USC-10M038, NCT00089063

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000378169, UVACC-MEL-43, UVACC-28903, UVACC-HIC-10524, FCCC-03045, MDA-2003-0720, NCT00089193

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: 10049, UVACC-MEL-42, UVACC-24802, UVACC-HIC-10049, NCT00089206

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EPIMMUNE-EP2101-201, MCMRC-0461, NCT00104780

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02652, GCC-0430, CDR0000428259, MSGCC-GCC-0430, 6991, NCI-6991, NCT00109811

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-06-C-0041, 7542, NCI-7542, NCI-P6702, NCT00295958

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 060069, 06-C-0069, NCI-06-C-0069, 7676, NCI-7676, NCI-P6703, NCT00304057, NCT00273910

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10134, UVACC-OVA-2, UVACC-PRC-236-02, OVA-2, UVACC-HIC-10134, NCT00373217

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-06-C-0159, NCI-P6951, MDX-NCI-06-C-0159, NCT00357461

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-06051, NCT00267085
1    
New Search